Skip to main content

At 8.0% CAGR, Human Rabies Immunoglobulin (IM) Market Size Poised to Touch USD 450 million by 2024

Market Study Report LLC Add New Global Human Rabies Immunoglobulin (IM) Market Report to its research database. The report presents a deep study of the market growth factors and drivers. The report spread across 163 pages with table and figures in it.

Delaware, Selbyville - July 29, 2019 /MarketersMedia/

According to this study, over the next five years the Human Rabies Immunoglobulin (IM) market will register a 8.0% CAGR in terms of revenue, the global market size will reach US$ 450 million by 2024, from US$ 290 million in 2019.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1667763/?utm_source=MarketersMedia&utm_medium=MM

The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.

For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU.

Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%.

China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions and countries.

This study considers the Human Rabies Immunoglobulin (IM) value and volume generated from the sales of the following segments:

Segmentation by product type

• ERIG
• HRIG

Segmentation by application

• Category II Exposure
• Category III Exposure

This report also splits the market by region

• Americas [United States, Canada, Mexico, Brazil]
• APAC [China, Japan, Korea, Southeast Asia, India, Australia]
• Europe [Germany, France, UK, Italy, Russia, Spain]
• Middle East & Africa [Egypt, South Africa, Israel, Turkey, GCC Countries]

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report

• CSL Behring
• Grifols
• Sanofi
• Sichuan Yuanda Shuyang
• CNBG
• Kamada
• CBPO
• Shuanglin Bio
• Weiguang Bio
• Shanghai RAAS
• Bharat Serum
• VINS

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1667763/?utm_source=MarketersMedia&utm_medium=MM

Table of Contents:

2019-2024 Global Human Rabies Immunoglobulin (IM) Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Rabies Immunoglobulin (IM) Consumption 2014-2024
2.1.2 Human Rabies Immunoglobulin (IM) Consumption CAGR by Region
2.2 Human Rabies Immunoglobulin (IM) Segment by Type
2.2.1 ERIG
2.2.2 HRIG
2.3 Human Rabies Immunoglobulin (IM) Consumption by Type
2.3.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2014-2019)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2014-2019)
2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2014-2019)
2.4 Human Rabies Immunoglobulin (IM) Segment by Application
2.4.1 Category II Exposure
2.4.2 Category III Exposure
2.5 Human Rabies Immunoglobulin (IM) Consumption by Application
2.5.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2014-2019)
2.5.2 Global Human Rabies Immunoglobulin (IM) Value and Market Share by Application (2014-2019)
2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2014-2019)

3 Global Human Rabies Immunoglobulin (IM) by Players
3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2017-2019)
3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2017-2019)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players
3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Players (2017-2019)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2017-2019)
3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Players
3.4 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Human Rabies Immunoglobulin (IM) by Regions
4.1 Human Rabies Immunoglobulin (IM) by Regions
4.1.1 Global Human Rabies Immunoglobulin (IM) Consumption by Regions
4.1.2 Global Human Rabies Immunoglobulin (IM) Value by Regions
4.2 Americas Human Rabies Immunoglobulin (IM) Consumption Growth
4.3 APAC Human Rabies Immunoglobulin (IM) Consumption Growth
4.4 Europe Human Rabies Immunoglobulin (IM) Consumption Growth
4.5 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Growth

5 Americas
5.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries
5.1.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
5.1.2 Americas Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
5.2 Americas Human Rabies Immunoglobulin (IM) Consumption by Type
5.3 Americas Human Rabies Immunoglobulin (IM) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries
6.1.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2014-2019)
6.1.2 APAC Human Rabies Immunoglobulin (IM) Value by Countries (2014-2019)
6.2 APAC Human Rabies Immunoglobulin (IM) Consumption by Type
6.3 APAC Human Rabies Immunoglobulin (IM) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
Continued………

More Details on this Report At: https://www.marketstudyreport.com/reports/global-human-rabies-immunoglobulin-im-market-growth-2019-2024?utm_source=MarketersMedia&utm_medium=MM

Read More:
https://www.marketwatch.com/press-release/at-26-cagr-tourniquet-market-size-set-to-register-990-million-usd-by-2024-2019-07-26

https://www.marketwatch.com/press-release/at-40-cagr-respiratory-devices-market-size-set-to-register-5820-million-usd-by-2024-2019-07-26

https://www.marketwatch.com/press-release/at-29-cagr-medical-robots-market-size-to-surpass-us-3110-million-by-2024-2019-07-26

https://www.marketwatch.com/press-release/industrial-fabrics-market-size-to-exceed-us17000-mn-by-2024-cagr-27-2019-07-26

https://www.marketwatch.com/press-release/at-51-cagr-smart-card-market-size-to-surpass-usd-10200-million-by-2024-2019-07-23

https://www.marketwatch.com/press-release/at-72-cagr-sports-protective-equipment-market-size-to-hit-usd-14300-million-by-2024-2019-07-23

https://www.marketwatch.com/press-release/at-57-cagr-stainless-insulated-bottle-market-size-to-exceed-usd-5440-million-by-2024-2019-07-23

https://www.marketwatch.com/press-release/water-analysis-instrumentation-market-size-worth-usd-3290-million-by-2024-cagr-49-2019-07-23

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com

Source URL: https://marketersmedia.com/at-80-cagr-human-rabies-immunoglobulin-im-market-size-poised-to-touch-usd-450-million-by-2024/88902213

Source: MarketersMedia

Release ID: 88902213

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.